KNSA Stock: Price, Earnings History and SEC Filings
Kiniksa Pharmaceuticals International, plc (KNSA) last traded at $92.24, down 5.45% on the latest session and up 23.6% over the past month. In its most recent reported quarter (Sep 2026) earnings per share were $0.56 against an analyst estimate of $0.32, a beat of 75.0%.
$92.24 -5.45%
1 month+23.63%
52-week high$98.48
52-week low$36.56
Volume1.32M
ExchangeNasdaqGS
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
KNSA earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Sep 2026 | Oct 27, 2026 | $0.56 | $0.32 | +75.00% |
| Jun 2026 | Jul 28, 2026 | $0.30 | $0.30 | +0.00% |
| Mar 2026 | Apr 28, 2026 | $0.27 | $0.18 | +50.00% |
| Dec 2025 | Feb 24, 2026 | $0.17 | $0.29 | -41.38% |
KNSA beat the analyst EPS estimate in 2 of its last 4 reported quarters. Source: Nasdaq.
Latest SEC filings for KNSA
SEC filing data is not available right now. You can search for KNSA on SEC EDGAR.
KNSA news
- Stock Market: Google, Amazon, Intel, ServiceNow Trigger Tech Wreck, But Other Sectors Solid: Weekly ReviewOct 30, 2026 · finance.yahoo.com
- Kiniksa (KNSA) Stock Jumps As Q3 Results Fuel Growth DebateOct 28, 2026 · finance.yahoo.com
- Kiniksa Pharmaceuticals: 3 Key Takeaways for Long-Term InvestorsOct 27, 2026 · fool.com
- Kiniksa Pharmaceuticals, Ltd. Q3 2026 Earnings Call SummaryOct 27, 2026 · app.moby.co
- Kiniksa (KNSA) Q3 2026 Earnings Call TranscriptOct 27, 2026 · fool.com
- What Kiniksa Pharmaceuticals International (KNSA) Said on Its Q3 Earnings CallOct 27, 2026 · marketbeat.com
- Kiniksa Pharmaceuticals International, plc (KNSA) Q3 Earnings and Revenues Surpass EstimatesOct 27, 2026 · finance.yahoo.com
- Kiniksa Pharmaceuticals Reports Third Quarter 2026 Financial Results and Recent Portfolio ExecutionOct 27, 2026 · finance.yahoo.com
About Kiniksa Pharmaceuticals International, plc
Kiniksa Pharmaceuticals International, plc (KNSA) is a US-listed public company on Nasdaq.